Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Optomed Oyj

OPTOMED:HEX

Optomed Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)6.20
  • Today's Change0.10 / 1.64%
  • Shares traded51.98k
  • 1 Year change+87.59%
  • Beta2.5823
Data delayed at least 15 minutes, as of Jun 18 2024 17:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Optomed Oyj grew revenues 3.00% from 14.66m to 15.10m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -5.47m to -4.44m.
Gross margin66.76%
Net profit margin-29.25%
Operating margin-27.56%
Return on assets-15.21%
Return on equity-22.70%
Return on investment-18.59%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Optomed Oyj fell by 1.41m. Cash Flow from Financing totalled 1.61m or 10.66% of revenues. In addition the company used 616.00k for operations while cash used for investing totalled 2.41m.
Cash flow per share-0.1286
Price/Cash flow per share--
Book value per share1.08
Tangible book value per share0.2976
More ▼

Balance sheet in EURView more

Optomed Oyj has a Debt to Total Capital ratio of 18.94%, a lower figure than the previous year's 25.55%.
Current ratio2.25
Quick ratio1.72
Total debt/total equity0.2336
Total debt/total capital0.1894
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.